Charter Members of the Cancer Consortium. 


Travera is using a breakthrough technology to measure which cancer drugs work against each individual’s unique cancer cells. We are developing a universal biomarker for enabling oncologists to quickly determine which drugs to prescribe based on the actual responses of their patients’ tumor cells to candidate drugs. outlines the integrated communications platform created to foster collaboration among all those engaged in finding cures. 

© 2019 Altru Institute